Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Aficamten 💬[1] Aficamten (N-- 1-methyl-1h-pyrazole-4-carboxamide)[1] Aficamten[5] MYH6_7,
MYH6_7,
MYL2,
MYL3,
MYL4 💬
[17] Adherens junction, Adrenergic signaling in cardiomyocytes, Apelin signaling pathway, Cardiac muscle contraction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Focal adhesion, Hypertrophic cardiomyopathy, Leukocyte transendothelial migration, Motor proteins, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Viral myocarditis, cGMP-PKG signaling pathway 💬[1] 58 💬
2 Berotralstat 💬[1] Berotralstat (1H-pyrazole-5-carboxamide dihydrochloride)[2] BCX7353; Berotralstat[1] KLKB1 💬 [1] Complement and coagulation cascades 💬[1] 65 💬
3 Berotralstat hydrochloride 💬[1] Berotralstat (1H-pyrazole-5-carboxamide dihydrochloride)[2] BCX7353; Berotralstat[1] KLKB1 💬 [1] Complement and coagulation cascades 💬[1] 65 💬
4 Pirtobrutinib 💬[1] Pirtobrutinib (1h-pyrazole-4-carboxamide)[1] Pirtobrutinib[1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 13 💬